GDF15 and sarcopenia: Nevertheless, more studies are needed to evaluate the clinical usability of GDF‐15 as a marker of frailty or sarcopenia and to investigate the prognostic value of GDF‐15 in terms of predicting both geriatric syndromes as well as adverse outcomes related to older age, such as prolonged length of stay, decreased functional ability, and mortality.